Literature DB >> 12120259

New horizons--alternative routes for insulin therapy.

David R Owens1.   

Abstract

Since the introduction of insulin therapy 80 years ago, the lives of millions of patients with diabetes have been saved, prolonged and immeasurably improved. However, restoring normal glucose levels in diabetic patients through administering insulin by subcutaneous injection has proved virtually impossible. The consequences for patients are serious complications, including diabetic retinopathy and nephropathy, which tend to result from persistent hyperglycaemia. Maximizing glucose control in diabetic patients requires several daily injections. In an effort to reduce this burden, alternative and less-intrusive routes for the administration of insulin are being explored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12120259     DOI: 10.1038/nrd836

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  38 in total

Review 1.  Insulin therapy and cancer risk in diabetes mellitus.

Authors:  Julia Platts
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

Review 2.  Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria.

Authors:  Jianhai Yang; Zhiqiang Cao
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  A minimized human insulin-receptor-binding motif revealed in a Conus geographus venom insulin.

Authors:  John G Menting; Joanna Gajewiak; Christopher A MacRaild; Danny Hung-Chieh Chou; Maria M Disotuar; Nicholas A Smith; Charleen Miller; Judit Erchegyi; Jean E Rivier; Baldomero M Olivera; Briony E Forbes; Brian J Smith; Raymond S Norton; Helena Safavi-Hemami; Michael C Lawrence
Journal:  Nat Struct Mol Biol       Date:  2016-09-12       Impact factor: 15.369

4.  Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin.

Authors:  Pedro Fonte; Tiago Nogueira; Christiane Gehm; Domingos Ferreira; Bruno Sarmento
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

5.  Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.

Authors:  Jicheng Yu; Yuqi Zhang; Yanqi Ye; Rocco DiSanto; Wujin Sun; Davis Ranson; Frances S Ligler; John B Buse; Zhen Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

6.  Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.

Authors:  Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  Expert Rev Endocrinol Metab       Date:  2015-07-18

Review 7.  Clinical pharmacokinetics and pharmacodynamics of inhaled insulin.

Authors:  John S Patton; Julie G Bukar; Michael A Eldon
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Influence of stabilizers on the physicochemical characteristics of inhaled insulin powders produced by supercritical antisolvent process.

Authors:  Yong Ho Kim; Constantinos Sioutas; Katherine S Shing
Journal:  Pharm Res       Date:  2008-09-04       Impact factor: 4.200

9.  Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.

Authors:  L A Dailey; E Kleemann; M Wittmar; T Gessler; T Schmehl; C Roberts; W Seeger; T Kissel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

10.  Oral insulin delivery by means of solid lipid nanoparticles.

Authors:  Bruno Sarmento; Susana Martins; Domingos Ferreira; Eliana B Souto
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.